Results 261 to 270 of about 3,722,377 (405)

An uncommon multimodal management approach for low-grade appendiceal mucinous neoplasm with pseudomyxoma peritonei and mucinous borderline ovarian tumor. [PDF]

Ann Med Surg (Lond)
Singh DK, Dhakal I, Ghimire S, Pandit N, Sharma R, Dulal S.   +5 more
europepmc   +1 more source

Functioning Ovarian Tumors

Surgical Clinics of North America, 1947
openaire   +4 more sources

Decoding Triphenotypic Neutrophils in Cervical Cancer Evolution and Targeting SPP1+/GBP1+/ELOVL5+ Tumor‐Associated Neutrophils to Sensitize Immunotherapy

Advanced Science, EarlyView.
The functional schematic diagram of tumor associated neutrophils. Abstract Enhancing cervical cancer (CC) immunotherapy requires deciphering the heterogeneous tumor immune microenvironment (TIME), particularly neutrophil phenotypic dynamics. Here, 1) we collected 543 CC cases to find that patients with elevated neutrophil levels have a higher incidence
Xingyu Chang, Xinyu Qu, Tingting Ren, Tong Wu, Weiyong Gu, Jingxin Ding, Keqin Hua, Junjun Qiu   +7 more
wiley   +1 more source

SMoFFI-SegFormer: a novel approach for ovarian tumor segmentation based on an improved SegFormer architecture. [PDF]

Front Oncol
Xie Q, Huang J, Sun J, Huang C, Xu C.
europepmc   +1 more source

Halorotetin B, A Novel Terpenoid Compound Derived from Marine Ascidian, Suppresses Tumor Growth by Targeting the Cell Cycle Regulator UBE2C

Advanced Science, EarlyView.
Halorotetin B, a novel small‐molecule terpenoid identified from an edible marine ascidian, exhibits strong anti‐tumor activity both in vitro and in vivo through direct targeting UBE2C to induce tumor cell cycle arrest and then lead tumor cell senescence. As a newly discovered UBE2C inhibitor, Halorotetin B can serve as a novel potential cell senescence
Shanhao Han, Jianhui Li, Yuting Zhu, Penghui Liu, Yaoyao Zheng, Muchun He, Bo Dong   +6 more
wiley   +1 more source

Characteristics and potential diagnostic value of gut microbiota in ovarian tumor patients. [PDF]

Sci Rep
Gong W, Jin G, Bao Y, Liu Q, Ni M, Wang J, Mao S, Zhang Y, Zheng Z.   +8 more
europepmc   +1 more source

8661 A case of post-menopausal female with virilization due to Sertoli-Leydig cell ovarian tumor recurring in contralateral ovary 8 years later

Mashrutee Maharaul, Jeffrey L. Miller
openalex   +1 more source

Stimuli‐Responsive Supramolecular Biomaterials for Cancer Theranostics

Advanced Science, EarlyView.
The ultimate goal of cancer theranostics is to get imaging agents and therapeutic cargo to tumor sites when and where they are required. “Smart” systems should be developed. This review discusses the characteristics of physiological stimuli, types and action modes of external stimuli, construction approaches and working principles, as well as ...
Wenting Hu, Binglin Ye, Guocan Yu, Feihe Huang, Zhengwei Mao   +4 more
wiley   +1 more source

Liposomal Doxorubicin, but Not Platinum-Taxane, Supports MHC-II Expression and Immune Maturation in the Ovarian Tumor Microenvironment. [PDF]

Cancers (Basel)
Lee H, Chen XL, Ozmadenci D, Tahon E, Haanan TJ, Hill B, Khan SU, Boyer A, Schlaepfer DD, Stupack D.   +9 more
europepmc   +1 more source

The Putative Role of TP53 Alterations and p53 Expression in Borderline Ovarian Tumors - Correlation with Clinicopathological Features and Prognosis: A Mini-Review [PDF]

, 2017
Andrzej Semczuk, Marek Gogacz, Anna Semczuk‐Sikora, Maciej Jóźwik, Tomasz Rechberger   +4 more
openalex   +1 more source